What Does the Next Decade Have in Store for European Biotech?
Just like that, another decade has gone by. It’s time to look at what the…
04/01/2021 - 9 minutes
Karen O’Hanlon Cohrt
Karen O’Hanlon Cohrt is a Science Writer and Editor with a PhD in biotechnology from Maynooth University, Ireland.
A Look Back at the Past Decade of European Biotech
As we prepare to enter a new decade, we look back on the major milestones…
30/12/2020 - 15 minutes
Lyme Disease Vaccine Gets Pfizer’s Backing in €284M Deal
The French biotech Valneva will collaborate with Pfizer to develop and commercialize Valneva’s phase II-stage…
07/05/2020 - 4 minutes
Series A Round Boosts Swedish Synthetic Biology Player by €6.4M
The Swedish synthetic biology company EnginZyme has raised a Series A funding round to the…
27/04/2020 - 4 minutes
Idorsia’s Drug Improves Sleep in First Phase III Trial for Insomnia
The Swiss pharmaceutical company Idorsia has announced that its drug candidate daridorexant significantly improved sleep…
21/04/2020 - 3 minutes
Ipsen Resumes Phase III Testing for Rare Disease Drug and Abandons Pediatric Trial
The French pharmaceutical company Ipsen has restarted the dosing of its treatment for a rare…
31/03/2020 - 4 minutes
How Much Salary Can You Expect in a Biotech Job?
If you’re thinking of taking a job in biotech, you’re probably wondering how much you’ll…
20/01/2020 - 7 minutes
Where Does Brexit Leave European Biotech?
In the next couple of months, the UK will officially exit the EU, in a…
25/03/2019 - 9 minutes
The European Fight Against NASH, The Silent Liver Disease
Today is the First International NASH Day, and to mark the occasion, we bring you…
12/06/2018 - 9 minutes
The 5 Best-Selling European Drugs of 2017
Biologicals have completely changed the way we treat diseases, and their growth has exploded in…
30/04/2018 - 7 minutes
Money, Money, Money! Europe’s Best-Funded Biotechs in 2018
Besides struggling with ambitious New Year’s resolutions and post-holiday diets, January is a time where…
20/02/2018 - 11 minutes
